CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
106 hedge funds and large institutions have $3.82B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $3.49B → $3.82B (+$328M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
106
Holding in Top 10
2
Calls
$17M
Puts
$4.33M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$22.8M | |
| 3 | +$6.59M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.19M |
| 5 |
BlackRock
New York
|
+$3.94M |
Top Sellers
| 1 | -$39.5M | |
| 2 | -$12.5M | |
| 3 | -$10.9M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$9.73M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.74M |